BRISTOL MYERS SQUIBB CO's ticker is and the CUSIP is 110122908. A total of 12 filers reported holding BRISTOL MYERS SQUIBB CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,699,000 | +19.9% | 160,000 | +32.1% | 0.13% | -1.5% |
| Q2 2021 | $8,092,000 | +414.8% | 121,100 | +386.3% | 0.13% | +428.0% |
| Q1 2021 | $1,572,000 | +1.8% | 24,900 | -2.0% | 0.02% | +4.2% |
| Q3 2020 | $1,544,000 | -67.9% | 25,400 | -69.0% | 0.02% | -80.3% |
| Q2 2020 | $4,816,000 | -82.3% | 81,900 | -83.2% | 0.12% | -78.4% |
| Q1 2020 | $27,212,000 | +474.5% | 488,200 | +561.5% | 0.56% | +212.2% |
| Q4 2019 | $4,737,000 | +32.3% | 73,800 | +4.5% | 0.18% | +11.7% |
| Q3 2019 | $3,580,000 | +214.0% | 70,600 | +195.4% | 0.16% | +153.1% |
| Q1 2019 | $1,140,000 | -71.2% | 23,900 | -4.4% | 0.06% | -71.0% |
| Q4 2018 | $3,965,000 | +145.7% | 25,000 | -3.8% | 0.22% | +179.7% |
| Q3 2018 | $1,614,000 | -45.8% | 26,000 | -51.7% | 0.08% | -44.8% |
| Q2 2018 | $2,977,000 | -42.4% | 53,800 | -34.1% | 0.14% | -39.9% |
| Q1 2018 | $5,168,000 | -25.0% | 81,700 | -27.4% | 0.24% | -19.9% |
| Q4 2017 | $6,894,000 | – | 112,500 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 400,000 | $23,668,000 | 1.40% |
| PFM Health Sciences, LP | 612,000 | $36,212,000 | 1.06% |
| CMT Capital Markets Trading GmbH | 1,002,400 | $60,765,000 | 0.37% |
| Capital Markets Trading UK LLP | 160,000 | $9,699,000 | 0.13% |
| GROUP ONE TRADING, L.P. | 987,500 | $58,430,000 | 0.06% |
| SIMPLEX TRADING, LLC | 698,700 | $46,505,000 | 0.04% |
| Maven Securities LTD | 9,100 | $538,000 | 0.02% |
| WELLS FARGO & COMPANY/MN | 1,007,500 | $59,613,000 | 0.01% |
| Allianz Asset Management GmbH | 86,100 | $5,095,000 | 0.00% |
| JPMORGAN CHASE & CO | 134,000 | $7,929,000 | 0.00% |